The intersection of technology, pharmaceuticals, and gene editing is seen in the efforts of drug companies to patent natural substances like psilocybin in mushrooms for medical use. Gene editing has revolutionized life sciences, human health, agriculture, and industrial biotechnology. AI is enabling the creation of improved tools in gene editing, providing significant benefits to humanity. Leveraging open source tools in gene editing may lead to the emergence of startups similar to the dot org and dot com versions in other technology sectors. The patent landscape associated with gene editing technologies like CRISPR could potentially hinder innovation and product development in the startup community, emphasizing the importance of open-source tools for technology advancement and humanity's progress.